Vemurafenib: Targeted inhibition of mutated BRAF for treatment of advanced melanoma and its potential in other malignancies

Anant Sharma, Sachin R. Shah, Henrik Illum, Jonathan Dowell

Research output: Contribution to journalReview articlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Vemurafenib: Targeted inhibition of mutated BRAF for treatment of advanced melanoma and its potential in other malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences